Phi Therapeutics

Phi Therapeutics is a venture-backed biotech startup focused on the microbiome, based in San Francisco and led by scientists from UCSF and Johns Hopkins University. Phi's mission is to change the way we treat chronic bacterial diseases. The revolutionary microbiome editing platform developed with Phi's technology is creating safer and more effective products for chronic skin diseases, like acne and eczema.